Investors had many things to digest this week, including a continued pause in interest rates by the Federal Reserve, earnings reports from four of the Magnificent Seven companies, and the escalation of hostilities between the U.S. and Iran. The common denominator for all of these is inflation. Ther....
Good MorningU.S. stocks moved higher Friday, with the Nasdaq advancing as Amazon rallied following earnings and Alphabet also supported the major indexes. The Dow gained ground despite higher yields, while Apple shares fell after a weak sales forecast. Market attention remained fixed on Big Tech spending, AI infrastructure and the durability of semiconductor demand.
Amazon highlighted faster delivery initiatives and expanding robotics deployment, while Alphabet reported strong Search and Cloud growth but faced scrutiny over sharply higher capital expenditures and weaker free-cash-flow conversion. Memory-chip stocks remained volatile, with Micron giving back part of its prior gains even as major technology companies pointed to ongoing memory shortages.
Deal activity also lifted Ambarella after reports that NXP Semiconductors is in talks to acquire the automotive and AI camera-chip designer, though NXP shares declined. In health care, Novo Nordisk fell after a late-stage heart disease drug candidate failed, while BrightSpring reported an upbeat quarter and projected 2026 adjusted EBITDA of $820 million to $845 million. Investors are also preparing for a potentially difficult retail earnings season, with sales growth likely to receive more attention than tariff-related margin effects. Featured: Backed Company Could Save Power Grid (Ad) 
|
Markets |
|
Investors had many things to digest this week, including a continued pause in interest rates by the Federal Reserve, earnings reports from four of the Magnificent Seven companies, and the escalation of hostilities between the U.S. and Iran. The common denominator for all of these is inflation. Ther... Read the Full Story |
|
From Our Partners |
|
For a moment…
Forget about Trump’s ties to Israel.
Forget about reports of Iran’s nuclear program.
Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason. |
| Click here to find out what it is. |
|
Energy |
|
It doesn’t come as a big surprise that Chevron (NYSE: CVX) just posted one of its strongest quarters in years. Second-quarter 2026 earnings hit $12.1 billion, or $6.11 per diluted share. Adjusted earnings came in at $12.0 billion, or $6.06 per share. Both numbers dwarf last year's second quarter, w... Read the Full Story |
|
Consumer Discretionary |
|
For most of this year, Amazon.com Inc. (NASDAQ: AMZN) has been dogged by a single nagging question: would its enormous spending on artificial intelligence (AI) infrastructure ever translate into faster growth? Its Q2 earnings report, delivered Thursday night, offered the most emphatic answer yet, a... Read the Full Story |
|
From Our Partners |
|
Since 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every dollar while paying savers just 0.04 percent interest.
A new law, the GENIUS Act signed last summer, has cleared the way for a different kind of money to emerge this spring, one that could offer savings rates up to 6 percent.
See what Ian King, Chief Strategist at Strategic Fortunes, has uncovered about this shift before it goes live. |
| Click here to see what Ian King found about this new savings shift |
|
Technology |
|
Just before reporting earnings, the question hanging over Apple Inc. (NASDAQ: AAPL) was whether a stock sitting at record highs could still be a buy. The company's report has answered that question in the most frustrating way imaginable for its bulls: with an excellent quarter the market chose to h... Read the Full Story |
|
Healthcare |
|
McKesson (NYSE: MCK) keeps moving medicines around the country and that keeps the money coming in. The company operates in the unglamorous middle of healthcare. It distributes enormous amounts of pharmaceuticals, serves specialty medical practices, and, behind the scenes, has been reshaping its bu... Read the Full Story |
|
From Our Partners |
|
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and stinging losses? Dave Aquino is giving away the exact 11-hour options strategy he uses in volatile markets. You get the plain English blueprint behind the strategy and the very same "rinse and repeat" ticker he's traded nearly 900 times with a 95.3% success rate. It's so simple to understand, you could trade it tomorrow. |
|
|
|
Consumer Discretionary |
|
When a legacy automaker reports a decisive earnings beat and raises full-year guidance, the market naturally reacts with enthusiasm. The headline numbers for the second quarter paint an undeniable picture of operational momentum for Ford Motor (NYSE: F). Management delivered adjusted earnings of 4... Read the Full Story |
|
Industrials |
|
For decades, the financial markets viewed standby generators as a cyclical housing play. Investors bought Generac (NYSE: GNRC) ahead of hurricane season and trimmed their position when the skies cleared. That playbook is officially obsolete. Generac has fundamentally decoupled from cyclical housing... Read the Full Story |
|
Technology |
|
Few companies have benefited more from the AI gold rush than ASML Holdings N.V. (NASDAQ: ASML), which has a monopoly on a key bottleneck in the semiconductor pipeline. But its grip on the market was shaken this week by reports that a Chinese competitor has begun producing similar lithography mach... Read the Full Story |
|
Consumer Discretionary |
|
Brian Niccol is the best thing to happen to Chipotle Mexican Grill (NYSE: CMG) since its IPO. His leadership brought an ailing company and troubled brand out of the dumps and established it as a leader in fast-casual dining, outpacing peers while driving profitable growth. His loss was a loss for ... Read the Full Story |
|
Industrials |
|
L3Harris Technologies (NASDAQ: LHX) is a great example of a massive disconnect in the market. Geopolitical headwinds, macroeconomic fears, and general market angst have high-quality stocks in correction and trading in bear markets despite otherwise healthy fundamental conditions and robust outlooks... Read the Full Story |
|
The Early Bird Stock Of The Day UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing th... |
Should I Buy UnitedHealth Group Stock? UNH Bull and Bear Case ExplainedThese insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of UnitedHealth Group was last updated on Tuesday, July 28, 2026 at 6:04 PM. UnitedHealth Group Bull Case
- The company has set its FY 2026 guidance at an earnings per share (EPS) range of 19.500-20.000, indicating strong future profitability expectations.
- UnitedHealth Group recently increased its quarterly dividend to $2.32 per share, up from $2.21, reflecting a commitment to returning value to shareholders.
- The current stock price is around $720, which may present a favorable entry point for investors looking to capitalize on the company's growth potential.
- With a dividend yield of 2.2% and a payout ratio of 59.72%, the company demonstrates a balanced approach to reinvesting profits while rewarding shareholders.
- UnitedHealth Group operates two primary business platforms, UnitedHealthcare and Optum, providing diversified revenue streams and reducing reliance on any single market segment.
UnitedHealth Group Bear Case
- Despite the positive outlook, the healthcare sector can be highly regulated, which may impact profitability and operational flexibility.
- Market volatility can affect stock performance, and the current economic climate may pose risks to growth projections.
- Increased competition in the healthcare space could pressure margins and market share, potentially affecting future earnings.
- While the dividend increase is a positive sign, any future cuts or freezes in dividends could negatively impact investor sentiment.
- Analysts predict earnings of 19.69 EPS for the current year, which, while positive, may not meet the higher expectations set by the company's guidance.
|
| View Today's Stock Pick |
|
|
|
